Zobrazeno 1 - 5
of 5
pro vyhledávání: '"José David Torres-Peña"'
Autor:
Luis M. Pérez-Belmonte, José David Torres-Peña, María D. López-Carmona, M. Mar. Ayala-Gutiérrez, Francisco Fuentes-Jiménez, Lucía Jorge Huerta, Jaime Alonso Muñoz, Manuel Rubio-Rivas, Manel Madrazo, Marcos Guzmán Garcia, Beatriz Vicente Montes, Joaquim Fernández Sola, Javier Ena, Ruth Gonzalez Ferrer, Carmen Mella Pérez, Carlos Jorge Ripper, Jose Javier Napal Lecumberri, Iris El Attar Acedo, Susana Plaza Canteli, Sara Fuente Cosío, Francisco Amorós Martínez, Begoña Cortés Rodríguez, Pablo Pérez-Martínez, José Manuel Ramos-Rincón, Ricardo Gómez-Huelgas, for the SEMI-COVID-19 Network
Publikováno v:
BMC Medicine, Vol 18, Iss 1, Pp 1-10 (2020)
Abstract Background Limited evidence exists on the role of glucose-lowering drugs in patients with COVID-19. Our main objective was to examine the association between in-hospital death and each routine at-home glucose-lowering drug both individually
Externí odkaz:
https://doaj.org/article/075d60a7a4074e35b070c9194fc6a79a
Autor:
Francisco Javier Carrasco-Sánchez, Mª Dolores López-Carmona, Francisco Javier Martínez-Marcos, Luis M. Pérez-Belmonte, Alicia Hidalgo-Jiménez, Verónica Buonaiuto, Carmen Suárez Fernández, Santiago Jesús Freire Castro, Davide Luordo, Paula Maria Pesqueira Fontan, Julio César Blázquez Encinar, Jeffrey Oskar Magallanes Gamboa, Andrés de la Peña Fernández, José David Torres Peña, Joaquim Fernández Solà, Jose Javier Napal Lecumberri, Francisco Amorós Martínez, María Esther Guisado Espartero, Carlos Jorge Ripper, Raquel Gómez Méndez, Natalia Vicente López, Berta Román Bernal, María Gloria Rojano Rivero, José Manuel Ramos Rincón, Ricardo Gómez Huelgas
Publikováno v:
Annals of Medicine, Vol 53, Iss 1, Pp 103-116 (2021)
AbstractBackground Hyperglycaemia has emerged as an important risk factor for death in coronavirus disease 2019 (COVID-19). The aim of this study was to evaluate the association between blood glucose (BG) levels and in-hospital mortality in non-criti
Externí odkaz:
https://doaj.org/article/72526d7459a0439baaa1dcf4081476d9
Autor:
Juan Luis Romero‐Cabrera, Antonio García‐Ríos, Mercedes Sotos‐Prieto, Gracia Quintana‐Navarro, Juan Francisco Alcalá‐Díaz, Laura Martín‐Piedra, José David Torres‐Peña, Raúl M. Luque, Elena María Yubero‐Serrano, Javier Delgado‐Lista, Niki Katsiki, Stefanos N. Kales, José López‐Miranda, Pablo Pérez‐Martínez
Publikováno v:
Journal of Internal Medicine. 293:574-588
A Mediterranean lifestyle may prevent and mitigate cardiometabolic disorders. We explored whether adherence to a Mediterranean lifestyle was prospectively associated with risk of metabolic syndrome (MetS) among coronary heart disease (CHD) patients.T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a1aaa65f0b85638cff723bcc28966d8
https://doi.org/10.1111/joim.13602
https://doi.org/10.1111/joim.13602
Autor:
José Carlos Arévalo-Lorido, Juana Carretero-Gómez, Jose Manuel Casas-Rojo, Juan Miguel Antón-Santos, José Antonio Melero-Bermejo, Maria Dolores López-Carmona, Lidia Cobos Palacios, Jaime Sanz-Cánovas, Paula Maria Pesqueira-Fontán, Andrés Alberto de la Peña-Fernández, Navas-Maria de la Sierra Alcántara, Gema Maria García-García, José David Torres Peña, Jeffrey Oskar Magallanes-Gamboa, Rosa Fernández-Madera-Martinez, Javier Fernández-Fernández, Manuel Rubio-Rivas, Guillermo Maestro-de la Calle, Eva Cervilla-Muñoz, Antonio Ramos-Martínez, Manuel Méndez-Bailón, José Manuel Ramos-Rincón, Ricardo Gómez-Huelgas
The individual influence of a variety of comorbidities on COVID-19 patient outcomes has already been analyzed in previous works in an isolated way. We aim to determine if different associations of diseases influence the outcomes of inpatients with CO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d448569627295e691d98045d0a0d2f6
Autor:
Luis Miguel Pérez-Belmonte, José David Torres-Peña, María D. López-Carmona, M. Mar Ayala-Gutiérrez, Francisco Fuentes-Jiménez, Lucía Jorge Huerta, Jaime Alonso Muñoz, Manuel Rubio-Rivas, Manel Madrazo, Marcos Guzmán Garcia, Beatriz Vicente Montes, Joaquim Fernández Sola, Javier Ena, Ruth Gonzalez Ferrer, Carmen Mella Pérez, Carlos J. Ripper, Jose Javier Napal Lecumberri, Iris El Attar Acedo, Susana Plaza Canteli, Sara Fuente Cosío, Francisco Amorós Martínez, Begoña Cortés Rodríguez, Pablo Pérez-Martínez, José M. Ramos-Rincón, Ricardo Gómez-Huelgas
Publikováno v:
SSRN Electronic Journal.
Background: Limited evidence exists on the role of glucose-lowering drugs in patients with COVID-19 This work examines the impact of each at-home glucose-lowering drugs individually or in combination with metformin on mortality and other adverse outc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b6aa23c729948abcf09c5ccf943dede
https://doi.org/10.2139/ssrn.3666251
https://doi.org/10.2139/ssrn.3666251